These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Retraction: Randomized controlled trial of the effect of bilateral uterine artery ligation during cesarean among women at risk of uterine atony. Int J Gynaecol Obstet; 2024 Jul; 166(1):475. PubMed ID: 38703019 [TBL] [Abstract][Full Text] [Related]
44. Retracted: Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene, Prevents the Developing of Atherosclerotic Lesions and Attenuates Cholesterol Accumulation in Macrophage Foam Cells. Hong M; Li J; Li S; Almutairi MM Mol Nutr Food Res; 2023 Oct; 67(19):e2370500. PubMed ID: 37793800 [TBL] [Abstract][Full Text] [Related]
52. Retraction: Concordance and characterization of massively parallel sequencing at 58 STRs in a Tibetan population. Mol Genet Genomic Med; 2024 Feb; 12(2):e2383. PubMed ID: 38345354 [TBL] [Abstract][Full Text] [Related]
53. Retraction: Celastrol inhibit the proliferation, invasion and migration of human cervical HeLa cancer cells through down-regulation of MMP-2 and MMP-9. J Cell Mol Med; 2024 May; 28(9):e18326. PubMed ID: 38682752 [TBL] [Abstract][Full Text] [Related]
54. RETRACTION: Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. J Cell Physiol; 2024 Jul; ():e31356. PubMed ID: 39014938 [TBL] [Abstract][Full Text] [Related]